[HTML][HTML] Autoantibodies in the diagnosis, prognosis, and prediction of colorectal cancer

R Niloofa, MI De Zoysa… - Journal of Cancer …, 2021 - journals.lww.com
Colorectal cancer (CRC) is the second-most commonly diagnosed cancer worldwide. Early
diagnosis improves prognosis and long-term outcomes. Several studies have found tumor …

Autoantibodies in the diagnosis, prognosis, and prediction of colorectal cancer.

R Niloofa, MI De Zoysa… - Journal of Cancer …, 2021 - europepmc.org
Colorectal cancer (CRC) is the second-most commonly diagnosed cancer worldwide. Early
diagnosis improves prognosis and long-term outcomes. Several studies have found tumor …

Autoantibodies in the diagnosis, prognosis, and prediction of colorectal cancer.

R Niloofa, M De Zoysa, L Seneviratne - Journal of Cancer Research …, 2021 - go.gale.com
Colorectal cancer (CRC) is the second-most commonly diagnosed cancer worldwide. Early
diagnosis improves prognosis and long-term outcomes. Several studies have found tumor …

Autoantibodies in the diagnosis, prognosis, and prediction of colorectal cancer

R Niloofa, MI De Zoysa… - Journal of cancer …, 2021 - pubmed.ncbi.nlm.nih.gov
Colorectal cancer (CRC) is the second-most commonly diagnosed cancer worldwide. Early
diagnosis improves prognosis and long-term outcomes. Several studies have found tumor …

Autoantibodies in the diagnosis, prognosis, and prediction of colorectal cancer.

R Niloofa, M De Zoysa… - Journal of Cancer …, 2021 - search.ebscohost.com
Colorectal cancer (CRC) is the second-most commonly diagnosed cancer worldwide. Early
diagnosis improves prognosis and long-term outcomes. Several studies have found tumor …